Relationship between pluripotency maintenance of residual embryonic stem cells and exogenous leukemia inhibitory factor

Journal of Shanghai Jiaotong University (Medical Science)

Volumn 29, Issue 8, 2009, Pages

  Pi, Qing Meng ^a   Fu, Wei ^a   Shi, Lun Gang ^a   Tang, Zheng Ya ^a   Cao, Yi Lin ^a   Zhang, Wen Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Differentiation; Embryonic stem cell; Leukemia inhibitory factor; Pluripotency; Residue

Indexed keywords

CD9 ANTIGEN; FIBROBLAST GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; LEUKEMIA INHIBITORY FACTOR; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; REX PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NANOG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; EMBRYONIC STEM CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; TERATOMA; TISSUE CULTURE;

EID: 77953456189     PISSN: 16748115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos[J]. Nature, 1981, 292(5819): 154-156.
2. Velev V, Vatev I. Embryonic stem cells-obtaining, characterization, application[J]. Akush Ginekol (Sofiia), 2007, 46(8): 11-15.
3. Cao F, van der Bogt KE, Sadrzadeh A, et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation[J]. Stem Cells Dev, 2007, 16(6): 883-891.
4. Fujikawa T, Oh SH, Pi L, et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells[J]. Am J Pathol, 2005, 166(6): 1781-1791. (Pubitemid 40734401)
5. Pomper MG, Hammond H, Yu X, et al. Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models[J]. Cell Res, 2009, 19(3): 370-379.
6. Cartwright P, McLean C, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism[J]. Development, 2005, 132(5): 885-896. (Pubitemid 40484924)
7. Raz R, Lee CK, Cannizzaro LA, et al. Essential role of STAT3 for embryonic stem cell pluripotency[J]. Proc Natl Acad Sci U S A, 1999, 96(6): 2846-2851. (Pubitemid 29148806)
8. Nakatsuji N. Embryonic stem cell, early development and cell differentiation[J]. Tanpakushitsu Kakusan Koso, 1991, 36(13): 2007-2012.
9. Furusawa T, Ikeda M, Inoue F, et al. Gene expression profiling of mouse embryonic stem cell subpopulations[J]. Biol Reprod, 2006, 75(4): 555-561. (Pubitemid 44465796)
10. Cui L, Johkura K, Yue F, et al. Spatial distribution and initial changes of SSEA-1 and other cell adhesion-related molecules on mouse embryonic stem cells before and during differentiation[J]. J Histochem Cytochem, 2004, 52(11): 1447-1457. (Pubitemid 39518680)
11. Matveeva NM, Shilov AG, Kaftanovskaya EM, et al. In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes[J]. Mol Reprod Dev, 1998, 50(2): 128-138.
12. Mitalipov ShM, Mitallipova MM, Ivanov VI. The effect of the duration of culturing on the pluripotency of mouse embryonic stem (ES) cells in vitro and in vivo[J]. Ontogenez, 1994, 25(6): 19-27.
13. Shellard J, Perreau J, Brulet P. Role of leukemia inhibitory factor during mammalian development[J]. Eur Cytokine Netw, 1996, 7(4): 699-712.
14. Enseñat-Waser R, Santana A, Vicente-Salar N, et al. Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking[J]. In Vitro Cell Dev Biol Anim, 2006, 42(5-6): 115-123. (Pubitemid 44744159)